Dual bronchodilation with tiotropium/olodaterol further reduces activity-related breathlessness <i>versus</i> tiotropium alone in COPD.

Eur Respir J · 2019 · PMC6437647 · PMID 30655277

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The TDI data in the present trial are also similar to those previously published, and although the treatment difference did not reach statistical significance, a clinically important mean improvement of >1 unit [ 16 ] from baseline was observed with tiotropium/olodaterol only.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.